Home parenteral nutrition (HPN) has benefited countless patients since its initiation almost 5 decades ago. Over time, HPN has been found to be associated with various complications, including metabolic disorders. Metabolic complications can be grouped into short-term (eg, fluid imbalance, electrolyte disturbances, glucose abnormalities) and long-term (eg, hepatobiliary disorders, metabolic bone disease, iron deficiency anemia, manganese toxicity) categories. There are a number of treatment options for each complication. It is important to evaluate the entire clinical picture prior to initiating an intervention and use evidence-based interventions when available. A dedicated multidisciplinary team is best suited to prevent and manage complications when they are identified.
de BurgoaLJSeidnerDHamiltonCet al. Examination of factors that lead to complications for new home parenteral nutrition patients. J Infus Nurs. 2006;29:74-80.
2.
RichardsDMDeeksJJSheldonTAet al. Home parenteral nutrition: a systematic review. Health Technol Assess. 1997;1:18-22.
3.
HerfindalETBernsteinLRWongAFet al. Complications of home parenteral nutrition. Clin Pharm. 1992;11:543-548.
4.
NaylorCJGriffithsRFernandezRS.Does a multidisciplinary total parenteral nutrition team improve patient outcome? A systematic review. JPEN J Parenter Enteral Nutr. 2004;28:251-258.
5.
VallabhHKonradDDeChiccoRet al. Thirty-day readmission rate is high for hospitalized patients discharged with home parenteral nutrition or intravenous fluids [published online August 18, 2016]. JPEN J Parenter Enteral Nutr.
6.
KonradDRobertsSCorriganML.Treating dehydration at home avoids healthcare costs associated with emergency department visits and hospital readmissions for adult patients receiving home parenteral support. Nutr Clin Pract. 2017;32:385-391.
7.
ArmstrongLE.Assessing hydration status: the elusive gold standard. J Am Coll Nutr. 2007;26:575S-584S.
ZerbeRIRobertsonGL.Osmoregulation of thirst and vasopressin secretion in human subjects: effect of various solutes. Am J Physiol. 1983;244:E607-E614.
10.
LangleyGTajchmanS. Fluid, electrolytes, and acid-base disorders. In: MuellerCMKovacevichDSMcClaveSAet al, eds. The ASPEN Nutrition Support Core Curriculum. 2nd ed.Silver Spring, MD: ASPEN; 2012:98-120.
11.
LauverjatMHadjAAVanhemsPet al. Chronic dehydration may impair renal function in patients with chronic intestinal failure on long-term parenteral nutrition. Clin Nutr. 2006;25:75-81.
12.
RhodaKMPorterMJQuintiniC.Fluid and electrolyte management: putting a plan in motion. JPEN J Parenter Enteral Nutrition. 2011;35: 675-685.
13.
Lennard-JonesJE.Review article: practical management of the short bowel. Aliment Pharmacol Ther. 1994;8:563-577.
14.
MessingBCrennPBeuaPet al. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterol. 1999;117:1043-1050.
15.
MatareseLEO’KeefeSJKandilHMet al. Short bowel syndrome: clinical guidelines for nutrition management. Nutr Clin Prac. 2005;20: 493-502.
16.
KonradDCorriganMLHamiltonCet al. Identification and early treatment of dehydration in home parenteral nutrition and home intravenous fluid patients prevents hospital admissions. Nutr Clin Pract. 2012;27:802-807.
17.
WinklerMHaganEAlbinaJE. Home nutrition support. In: MuellerCMKovacevichDSMcClaveSAet al, eds. The ASPEN Nutrition Support Core Curriculum. 2nd ed.Silver Spring, MD: ASPEN; 2012:639-655.
18.
CoxJAWestbrookLJO. Home infusion therapy: essential characteristics of a successful education process—a grounded theory study. J Infusion Nurs. 2005;28:99-107.
19.
Sand-JecklinK.The impact of medical terminology on readability of patient education materials. J Community Health Nurs. 2007;24:119-129.
20.
GiffordHDeLeggeMEppersonLA.Education methods and techniques for training home parenteral nutrition patients. Nutr Clin Pract. 2010;25:443-450.
21.
ParrishCR.A Patient’s Guide to Managing Short Bowel. 3rd ed.Westwood, MA: Universal Wilde; 2015.
22.
TarletonSDibaiseJK. Short bowel syndrome. In: MuellerCMKovacevichDSMcClaveSAet al, eds. The ASPEN Nutrition Support Core Curriculum. 2nd ed.Silver Spring, MD: ASPEN; 2012:511-522.
23.
JeppesenPBMortensenPB.Colonic digestion and absorption of energy from carbohydrates and medium-chain fat in small bowel failure. JPEN J Parenter Enteral Nutr. 1999;23:S101-S105.
ParrishCRDiBaiseJ.Part III: hydrating the adult patient with short bowel syndrome. Pract Gastroenterol. 2015;39:10.
26.
CorriganMLKirbyDF. The role of antimotility and antisecretory agents in the management of short bowel syndrome. In: DiBaiseJKParrishCRThompsonJS, eds. Short Bowel Syndrome: Practical Approach to Management. Boca Raton, FL: Taylor & Francis; 2016:217-226.
27.
LutarewychMABatlleCD. Disorders of potassium balance. In: AndrogueHJ, ed. Contemporary Management in Critical Care: Acid-Base and Electrolyte Disorders. Vol. 1, No. 2. New York, NY: Churchill Livingstone; 1991:193-232.
28.
BrownROHamrickKDDickersonRNet al. Hyperkalemia secondary to concurrent pharmacotherapy in a patient receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 1996;20:429-432.
29.
WhangRWhangDDRyanMP.Refractory potassium repletion: a consequence of magnesium deficiency. Arch Intern Med. 1992;152:40-45.
30.
TongGMRudeRK.Magnesium deficiency in critical illness. J Intensive Care Med. 2005;20:3-17.
31.
BrannanPGVergne-MariniPPakCYet al. Magnesium absorption in the human small intestine: results in normal subjects, patients with chronic renal disease, and patients with absorptive hypercalciuria. J Clin Invest. 1976;57:1412-1418.
DaceyMJ.Magnesium disorders. Crit Care Clin. 2001;17:155-173.
34.
FatemiSRyzenEFloresJet al. Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism. J Clin Endocrinol Metab. 1991;73:1067-1072.
35.
PeppersMPGehebMDesaiT.Endocrine crises: hypophosphatemia and hyperphosphatemia. Crit Care Clin. 1991;7:201-2014.
36.
TravisSFSugermanHJRubergRLet al. Alterations of red-cell glycolytic intermediates and oxygen transport as a consequence of hypophosphatemia in patients receiving intravenous hyperalimentation. N Engl J Med. 1971;285:763-768.
37.
FineAPattersonJ.Severe hyperphosphatemia following phosphate administration for bowel preparation in patients with renal failure: two cases and a review of the literature. Am J Kidney Dis. 1997;29:103-105.
38.
AusthofSIMitchellRKonradDet al. Management of nonadherence in the home parenteral nutrition patient. Support Line. 2016;38:7-10.
Edakkanambeth VarayilJYadavSMilesJMet al. Hyperglycemia during home parenteral nutrition administration in patients without diabetes. JPEN J Parenter Enteral Nutr. 2017;41:672-677.
42.
KumpfVJGervasioJ. Complications of parenteral nutrition. In: MuellerCMKovacevichDSMcClaveSAet al, eds. The ASPEN Nutrition Support Core Curriculum. 2nd ed.Silver Spring, MD: ASPEN; 2012:284-298.
43.
MontoriVMBistrianBRMcMahonMM.Hyperglycemia in acutely ill patients. JAMA. 2002;288:2167-2169.
44.
LinLYLinHCLeePCMaWYLinHD.Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. Am J Med Sci. 2007;333(5):261-265.
45.
CheungNWNapierBZaccariaCet al. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care. 2005;28(10):2367-2371.
46.
OlveiraGTapiaMJOconJet al. Parenteral nutrition–associated hyperglycemia in non–critically ill inpatients increases the risk of in-hospital mortality (multicenter study). Diabetes Care. 2013;36(5):1061-1066.
47.
van den BergheGWoutersPWeekersFet al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
48.
McClaveSATaylorBEMartindaleRGet al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN). JPEN J Parenter Enteral Nutr. 2016;40:159-211.
49.
WilliamsNWalesSBradleyAet al. Long-term glucose homeostasis in patients on home parenteral nutrition. Clin Nutr. 1996;15:141-142.
50.
MontoriVMBasuAErwinPGet al. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care. 2002;25(3):583-592.
51.
KatzMDErstadBL.Octreotide, a new somatostatin analogue. Clin Pharm. 1989;8:255-273.
52.
CavicchiMBeauPCrennPet al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Inten Med. 2000;132:525-532.
53.
KumpfV.Parenteral nutrition–associated liver disease in adult and pediatric patients. Nutr Clin Pract. 2006;21:279-290.
54.
KellyD.Intestinal failure–associated liver disease: what do we know today?Gastroenterology. 2006;130:S70-S77.
55.
SalvinoRGhantaRSeidnerDLet al. Liver failure is uncommon in adults receiving long-term parenteral nutritionJPEN J Parenter Enteral Nutr. 2006;30:202-208.
56.
FlemingCR.Hepatobiliary complications in adults receiving nutrition support. Digest Dis. 1994;12:191-198.
57.
XuZLiY.Pathogenesis and treatment of parenteral nutrition–associated liver disease. Hepatobiliary Pancreat Dis Int. 2012;11:586-593.
58.
WantenGJCalderPC.Immune modulation by parenteral lipid emulsions. Am J Clin Nutr. 2007;85:1171-1184.
59.
BuchmanALOpillaMKwasnyMet al. Risk factors for the development of catheter-related bloodstream infections in patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2014;38:744-749.
60.
XuZLiYWangJet al. Effects of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition–associated liver disease in adults. Clin Nutr. 2012;31:217-223.
61.
Anez-BustillosLDaoDT.Intravenous fat emulsion formulations for the adult and pediatric patient: understanding the differences. Nutr Clin Pract. 2016;31:596-609.
62.
BuchmanALMoukarzelAJendenDJet al. Low plasma free choline is prevalent in patients receiving long term parenteral nutrition and is associated with hepatic aminotransferase abnormalities. Clin Nutr. 1993;12:33-37.
63.
HvasCKodjabashiaKNixonEet al. Reversal of intestinal failure–associated liver disease (IFALD): emphasis on its multifactorial nature. Frontline Gastroenterol. 2016;7:114-117.
64.
KanisJAMeltonLJChristiansenCet al. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137-1141.
65.
Cohen-SolalMBaudoinCJolyFet al. Osteoporosis in patients on long-term home parenteral nutrition: a longitudinal study. J Bone Miner Res. 2003;18:1989-1994.
66.
HaderslevKTjellesenLHaderslevPStaunM.Assessment of the longitudinal changes in bone mineral density in patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004;28:289-294.
67.
Task Force for the Revision of Safe Practices for Parenteral Nutrition. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004;28:S39-S70.
68.
RamanMAghdassiEBaunMet al. Metabolic bone disease in patients receiving home parenteral nutrition: a Canadian study and review. JPEN J Parenter Enteral Nutr. 2006;30:492-496.
69.
PittasAGLaskowskiUKosLet al. Role of vitamin D in adults requiring nutrition support. JPEN J Parenter Enteral Nutr. 2010;34:70-78.
70.
BharadwajSGohelTDeenOet al. Prevalence and predictors of vitamin D deficiency and response to oral supplementation in patients receiving long-term home parenteral nutrition. Nutr Clin Pract. 2014;29:681-685.
CamaschellaC.Iron-deficiency anemia. N Engl J Med. 2015;372:1832-1843.
74.
HwaYLRashtakSKellyDGet al. Iron deficiency in long-term parenteral nutrition therapy. JPEN J Parenter Enteral Nutr. 2016;40:869-876.
75.
KhaodhiarLKeane-EllisonMTawaNEet al. Iron deficiency anemia in patients receiving home total parenteral nutrition. JPEN J Parenter Enteral Nutr. 2002;26:114-119.
76.
Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academies Press; 2000.
77.
Pluhator-MurtonMMFedorakRNAudetteRJet al. Trace element contamination of total parenteral nutrition: contribution of component solutions. JPEN J Parenter Enteral Nutr. 1999;23:222-227.
78.
SantosDDatoreuCMateusLet al. Manganese in human parenteral nutrition: considerations for toxicity and biomonitoring. Neurotoxicology. 2014;43:36-45.
79.
HardyIJGillandersLHardyG.Is manganese an essential supplement for parenteral nutrition?Curr Opin Clin Nutr Metab Care. 2008;11:289-296.
80.
VanekVWBorumPBuchmanEet al; Novel Nutrient Task Force, Parenteral Multi-Vitamin and Multi-Trace Element Working Group; American Society for Parenteral and Enteral Nutrition (ASPEN) Board of Directors. ASPEN positions paper: recommendations for changes in commercially available parenteral multi-vitamin and multi-trace element products. Nutr Clin Pract. 2012;27:440-491.
81.
WardleCAForbesARobertsNBet al. Hypermanganesemia in long-term intravenous nutrition and chronic liver disease. JPEN J Parenter Enteral Nutr. 1999;23:350-355.
82.
JinJSaquiOAllardJP. Effect of discontinuation of manganese supplementation from home parenteral nutrition solutions on whole-blood levels and magnetic resonance imaging of the brain: a 5-year cohort study [published online March 1, 2017]. JPEN J Parenter Enteral Nutr.
83.
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser.1994;843:1–129.
